Company: DMAAR
Filing Date: 2025-01-14
Form Type: POS AM
Source: 0001213900-25-003137
Chunk: 202

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-14
Form: POS AM
Chunk 202
---
 -managingsponsor investors (assuming no exercise of the underwriters over -allotmentoption):

| Founder Shares |     | Private Units |     | Public Units(1) |     | Approximate           
 Percentage of         
 Outstanding           
 Ordinary Shares(1)(2) |
| [_____]        |     | [_____]       |     | [_____]         |     | [____]%               |

____________ (1)The non -managingsponsor investors have expressed to us an interest in purchasing up to an aggregate of approximately $39.8million of the units in this offering at the offering price. There can be no assurance that the non -managingsponsor investors will acquire any units, either directly or indirectly, in this offering, or as to the amount of the units the non -managingsponsor investors will retain, if any, prior to or upon the consummation of our initial business combination. (2)Does not include the conversion of outstanding rights. No non -managingsponsor investor will own a material amount of the interests of the sponsor or more than 9.9% of the equity interests in the sponsor, and the non -managingsponsor investors do not, under the sponsor’s operating agreement, have the right to take part in or interfere in any manner with the management, conduct or control of the business of the sponsor nor have the right to vote on any matter relating to the sponsor, its business or affairs. In addition, except in the case of incapacity, the non -managingsponsor investors have no right to remove the managing member of the sponsor. Further, our securities owned by the sponsor may not be withdrawn by any non -managingsponsor investor, and such securities would only be distributed to members pursuant to the terms of the sponsor’s operating agreement in connection with a business combination (absent the dissolution of the sponsor). The managing member of the sponsor also has the authority to forfeit our securities held by the sponsor in connection with a business combination without the approval of the non -managingsponsor investors as long as all members are treated equally. Accordingly, none of the non -managingsponsor investors will have a material interest in the sponsor. In addition, no non -managingsponsor member will own more than 9.9% of the equity interests in us, except one non -ma nagingsponsor investor has expressed to us an interest in purchasing 19.9% of the units to be sold in this offering.